Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 1, 2011, Pages 72-77

  Takayanagi, Ryoichi ^a   Inoguchi, Toyoshi ^a,b   Ohnaka, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Bilirubin; Cohort; Diabetes; Gilbert syndrome; Gunn rat

Indexed keywords

ALBUMIN; BILIRUBIN; BILIVERDIN; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN A1C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE;

ALBUMINURIA; BILIRUBIN BLOOD LEVEL; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIABETOGENESIS; DISEASE EXACERBATION; DRUG EFFECT; ENZYME ACTIVITY; GILBERT DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IN VITRO STUDY; JAPAN; JAPANESE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PROTEIN EXPRESSION; REVIEW;

ANIMALIA; MUS; RATTUS NORVEGICUS;

EID: 78650751290     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-014FR     Document Type: Review

References (28)

1. Sesso HD, Buring JE, Christen WG, and et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008; 300: 2123-2133.
2. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321.
3. Inoguchi T, Battan R, Handler E, Sportsman JR, Health W, King GR. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992; 89: 11059-11063.
4. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
5. Inoguchi T, Li P, Umeda F, and et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-1945.
6. Hink U, Li H, Mollnau H, and et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88: E14-E22.
7. Kim YK, Lee MS, Son SM, and et al. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 2002; 51: 522-527.
8. Guzik TJ, Mussa S, Gastaldi D, and et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656-1662. (Pubitemid 34298608)
9. Inoguchi T, Sonta T, Tsubouchi H, and et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 2003; 14: S227-S232. (Pubitemid 36903930)
10. Sonta T, Inoguchi T, Tsubouchi H, and et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 2004; 37: 115-123. (Pubitemid 38746655)
11. Tanaka Y, Gleason CE, Tran PO, and et al. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 1999; 96: 10857-10862. (Pubitemid 29442234)
12. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046. (Pubitemid 17049750)
13. Kwak JY, Takeshige K, Cheung BS, Minakami S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim Biophys Acta 1991; 1076: 369-373.
14. Lanone S, Bloc S, Foresti R, and et al. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. Faseb J 2005; 19: 1890-1892. (Pubitemid 41598785)
15. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40: 8-23. (Pubitemid 24050206)
16. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995; 41: 1504-1508.
17. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16: 250-255.
18. Djoussé L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001; 87: 1196-1200.
19. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008; 121: 781-788.
20. Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 2007; 298: 1398-1400.
21. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354.
22. Ohnaka K, Kono S, Inoguchi T, and et al. Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Clin Pract 2010; 88: 103-110.
23. Fujii M, Inoguchi T, Sasaki S, and et al. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int 2010; 78: 905-919.
24. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.
25. Shiose A, Kuroda J, Tsuruya K, and et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 2001; 276: 1417-1423.
26. Geiszt M, Kopp JB, Várnai P, Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 2000; 97: 8010-8014.
27. Etoh T, Inoguchi T, Kakimoto M, and et al. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 2003; 46: 1428-1437.
28. Fujii M, Inoguchi T, Maeda Y, and et al. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int 2007; 72: 473-480.